YCOSES and plant fungal pathogens are limiting factors highly affecting public health and crop production. Some fungal strains have been documented to be resistant to the commonly used drugs. Therefore, finding out new and pivotal antifungal drugs is becoming a global priority. Herein, we evaluated the in vitro antifungal activities of different crude polar (methanol and ethyl acetate) and non-polar (chloroform and petroleum ether) extracts of the mostly untapped brown seaweed Hormophysa cuneiformis (order Fucales, Phaeophyceae), in the Egyptian coastal waters, against eight pathogenic fungi: Aspergillus flavus, A. fumigatus, Candida albicans and Trichosporonas ahii (as human pathogens), and Alternaria alternata, Cladosporium herbarum, Fusarium oxysporum and Penicillium digitatum (as plant pathogens). The agar well diffusion assay was applied. Our findings showed that the chloroform extract only exhibited a potential antifungal activity against all tested fungal isolates, particularly T. asahii, C. albicans, A. fumigatus and C. herbarum, while the other extracts had relatively no remarkable effects. The minimum inhibitory concentrations (MICs) ranged between 0.78 and 6.25µg.ml -1 and these values are very close to those of the standard antifungal drug amphotericin B (0.63-5µg.ml -1 ). GC-MS analysis of the crude chloroform extract revealed 45 different bioactive compounds, mainly including 18 different species of saturated, monounsaturated and polyunsaturated fatty acids (71.48%) and some essential oils. The major constituents were arachidonic (C20:4, ω-6; 16.18%), oleic (C18:1, ω-9; 15.61%), palmitic (C16:0; 9.18%) and dihomo-γ-linolenic (C20:3, ω-6; 8.97%) fatty acids.
Introduction
Fungi are an important component of most ecosystems on Earth; however some of them are considered main pathogenic invaders in immunocompromised persons, causing diverse kinds of mycoses with an increasing threat to human health (Abd Elmegeed et al., 2015; Ouf et al., 2016) . It is well known that infections caused by different human fungal pathogens such as Candida spp. and/or Aspergillus spp. can result in some serious diseases and even death (Brown et al., 2012) . Moreover, Candida albicans, a common colonizer of the mucosal surface of the gut, has been classified among the highest five infectious agent causing sepsis (Vincent et al., 2009) . Currently, invasive candidiasis is the most common fungal disease among hospitalized patients and it has been reported that it is responsible for mortality rates up to 40% even when patients are received an antifungal therapy (Garcia-Solache & Casadevall, 2010; Kullberg & Arendrup, 2015) . Likewise, the mold Aspergillus fumigatus is the most frequent cause of invasive fungal infection in immunosuppressed individuals, including patients receiving immunosuppressive Egypt. J. Bot. 59 , No. 3 (2019) SAMAR S. MOHAMED AND ABDULLAH A. SABER therapy for neoplastic or autoimmune diseases, organ transplant recipients, and AIDS patients. Also, it has been found that A. fumigatus primarily causes invasive infection in the lung and represents a major cause of morbidity and mortality ranging from 40~90% in high-risk populations (Dagenais & Keller, 2009 ).
On the other hand, plant diseases caused by fungal pathogens have been addressed as a worldwide economic threat to the agricultural sustainable development (Fisher et al., 2012 and Hamed et al., 2018) . Furthermore, postharvest fungal pathogens limit shelf-life of fresh commodities, contributing to a deterioration of quality, reduction of nutrients and market value, and high possibility of mycotox in contamination (El-Hossary et al., 2017) . Control and management of plant fungal infections is very important to produce healthy food crops and consequently this strategy will has significant positive impacts on agricultural use of lands, waters, fuels and other inputs (Dean et al., 2012; Martinelli et al., 2015) .
Since fungi are metabolically similar to mammalian cells, few pathogen-specific targets are available, making antifungal research more challenging (El-Hossary et al., 2017) . Given the harmful side effects of the synthetic fungicides on the environment and crops as well as the resistance developed to some of them, there is nowadays an urgent need to find out new and ecofriendly alternatives effective on different fungal classes (Righini et al., 2018) .
In general, the marine environments are characterized by structurally diverse and biologically active secondary metabolites and some of them have inspired the development of new bioactive compounds of therapeutic potential. Seaweeds (or marine macroalgae) in general produce a variety of bioactive compounds with a wide range of antimicrobial activity (Zerrifi et al., 2018) . Among these secondary metabolites, several pivotal compounds with noteworthy antifungal activities have been addressed and isolated from the seaweeds (Liu et al., 2013; El-Hossary et al., 2017) . For example, the natural antifungal Lobophorolide, a 22-membered cyclic lactone, had been isolated from the marine brown alga Lobophora variegata, growing in the Red Sea, Hurghada (Egypt) and the islands of the Bahamas. Lobophorolide exhibited a potent antifungal activity against the saprophytic deuteromycete Dendryphiella salina and the pathogenic ascomycete Lindra thalassiae. Also, this natural compound has an antifungal potential against the amphotericin-resistant-strain C. albicans (El-Hossary et al., 2017) .
In Egypt, seaweeds are widely distributed along coasts of the Mediterranean (e.g., Shabaka, 2018) and Red Seas (e.g., El-Sharouny et al. 2001) . They are rich resources of bioactive compounds with high possibility for use in promising development of recent pharmaceutical agents (Abdel-Raouf et al., 2008; Ibraheem et al., 2017 Ibraheem et al., 2012; El-Sheekh et al., 2014; Fathy et al., 2017; Ibraheem et al., 2017) .
The brown seaweed Hormophysa cuneiformis (J. F. Gmelin) P. C. Silva (Fucales, Phaeophyta) is one of the algal flora inhabiting the Egyptian Red Sea coast, mainly at Hurghada and Safaga cities (ElSharouny, 2001 ). To the best of our knowledge and the available literature, there have been no studies regarding the phytochemical and antimicrobial properties of this seaweed in the Egyptian water habitats. However, some little information about phytochemical constituents, antibacterial and antihyperlipidemic activities of this species [and its synonym H. triquetra (C.Agardh) Kützing] had been discussed worldwide in some previous studies (e.g., Heiba et al., 1997; El Shoubaky & Salem, 2014a, b; Abdel-Raouf et al., 2015) .
The aim of this work was to evaluate for the first time the in vitro antifungal activities of the different extracts (methanol, ethyl acetate, chloroform and petroleum ether) from the brown seaweed H. cuneiformis, not well studied in the Egyptian coastal waters, against eight human and plant fungal pathogens. Analysis of the crude seaweed chloroform extract, as the most potent one, for detecting the bioactive substances particularly fatty acids profiling was also carried out using a gas chromatography-mass spectrometry (GC-MS) approach.
Materials and Methods

Algal sampling and identification
Specimens of the brown seaweed Hormophysa cuneiformis (Figs. 1 A-B) were collected on October 26 th 2017 from the littoral zone of rocky shorelines in Hurghada city (27° 15′ 58.45″N, 33° 48′ 57.09″E), the Red Sea coast of Egypt. In the field, thalli were washed well to remove any epiphytes and sand particles, kept in sterile clean plastic bottles and then transported chilled in the ice-box to the laboratory. The algal specimens were washed well again in the lab using tap water to be completely free from any debris, salts and sand particles, and then shade-air dried at the room temperature. The samples were pulverized to a fine powder using an electric blender and then stored well in sterile clean plastic bags in the refrigerator until further studies. Thalli of H. cuneiformis were morphologically identified following the relevant literature adopted by Jha et al. (2009) and Dixon & Huisman (2015) . Voucher specimens of the brown seaweed H. cuneiformis including fixed materials (2% v/v formaldehyde final conc.) and herbarium sheets were deposited at the Phycology Unit (No. 341), the Botany Department, Faculty of Science at Ain Shams University (Cairo, Egypt).
Preparation of the seaweed extracts
The extraction process was performed separately using four different organic solvents in the order of increased polarity: Petroleum ether, chloroform, ethyl acetate and methanol.100gm of the finely powdered seaweed were added to 400ml of each solvent (1: 4 w/v) following the protocol adopted by Fathy et al. (2017) and the extraction process was then carried out by incubation in an orbital shaker (Unimax 2010, Heidolph Instruments, Schwabach, Germany) at 175rpm. The crude seaweed extracts were filtered after 6hr incubation through Whatman No.1 filter paper (Whatman International, Ltd., Maidstone, England) and then the seaweed material was re-suspended again in each solvent (1: 4 w/v) and filtered after 24hr to ensure exhaustive extraction occurred. The crude seaweed extracts were combined and the solvents were evaporated by a rotary evaporator (Büchi R-200, Marshall Scientific, Minnesota, USA) at 40°C. The crude seaweed extracts were fast-frozen in liquid nitrogen and stored at -20ºC until further use and re-dissolved in the respective solvent on application. 
Figs. 1 (A-B). Morphological characteristics of the brown seaweed
Fungal isolates used in this study
Eight human and plant pathogenic fungal species, including Aspergillus fumigatus, A. flavus, Candida albicans, Trichosporona sahii, Alternaria alternata, Cladosporium herbarum, Fusarium oxysporum and Penicillium digitatum, were used as tested organisms in this study. Yeast species were cultured on sabouraud dextrose agar at 30ºC for 24hr, while filamentous fungi were grown on potato dextrose agar at 28ºC for 4-7 days. The fungal isolates used in this study were kept at the Microbiology Department, Faculty of Science, Ain Shams University (Cairo, Egypt).
Inoculum preparation
Yeast inoculum suspensions were prepared following the NCCLS M27-A2 method (NCCLS, 2002a) . The turbidity was spectrophotometrically measured at a wavelength of 530nm and then was adjusted to match a 0.5 McFarland density standard, resulting in a concentration of 1-5 x10 . For filamentous fungal species, inoculum suspensions were prepared from fresh mature 3 to 5 days old cultures grown on potato dextrose agar slants. The colonies were covered with 5ml of sterile distilled water. Tween 20 (5%) was added to facilitate the preparation of fungal inocula. The suspensions were obtained by exhaustive scraping of the surface with a sterile loop. The inoculum size was determined spectrophotometrically at a wavelength of 530nm until reaching a transmittance level of 80-82% according to M38-Aguidelines (NCCLS, 2002b).
Screening antifungal activities of H. cuneiformis extracts
Antifungal activities of the different crude seaweed extracts were performed using the agar well-diffusion assay (Magaldi et al., 2004) . Yeast and fungal suspensions were streaked evenly on Mueller-Hinton agar plates (9cm in diameter) using sterile clean cotton swabs. After that, 6mm holes were aseptically punched using a sterile cork borer. 200µl of the standard antifungal medication "amphotericin B" (0.1mg.ml , w/v) were injected inside these wells. The inoculated plates were incubated at 30°C for 24hr for yeast species and 2-4 days for the filamentous fungal species. The assay was carried out in triplicates and the plates were carefully examined to detect presence or absence of the fungal growths, as well as to measure diameters of the inhibition zones. The results were expressed as mean values ± standard deviation.
Broth microdilution assay
The minimum inhibitory concentration (MIC) for the crude algal-chloroform extract was determined, as the only potent antifungal extract in this study, using broth microdilution assay according to CLSI document M38-A2 (2002) . MIC was performed in RPMI 1640 medium (Sigma-Aldrich, Mississauga, Ontario, Canada) with L-glutamine but without sodium bicarbonate and buffered with 0.165M morpholinepropanesulfonic acid (MOPS) (Sigma-Aldrich) at pH 7.0. A sterile microdilution plate (96-flat bottomed wells) was used for each strain so that 100µl of RPMI media were added to each well then another 100µl of the solution of standard antifungal drugor the crude chloroform extract of Hormophysa cuneiformis were added to a well in the 1 st column. Two-fold serial dilutions were made using the multichannel pipette so that rows 1-10 will contain the series of dilutions of the 100µl seaweed chloroform extracts. 100µl of inoculum suspension were added to each well. The 11 th row which served as the positive growth control contained 100µl of inoculum suspension and 100µl of free medium whereas the 12 th row which served as negative control only contained 200µl of RPMI broth. Microdilution trays were incubated at 30ºC. The MICs were read after 4-7 days. MIC was determined as the point at which there was 100% inhibition of the fungal growth as compared to the control when read visually in the microtitre plates (Hammer et al., 2003; da Silva Barros et al., 2007) .
Lipids extraction and transmethylation
Total lipids were extracted from the seaweed specimens following the method of Folch et al. (1957) . Briefly, the crude seaweed extract was resuspended in 10ml of chloroform/methanol 2:1 (v/v), sonicated for 15min in an ultrasonic bath (Sonorex Super, Bandelin electronics, Berlin, Germany), and centrifuged at 3000x g for 10min at room temperature to separate the organic phase (bottom layer). The procedure was repeated two times and the organic phases were collected, washed with 20ml of a 5% NaCl solution, filtered using glass filters and finally reduced to dryness on a rotary evaporator (BüchiLabortechnik AG, Flawil, Switzerland). Fatty acids methyl esters were prepared following a modified version of the procedure described by Mason & Waller (1964) . 250µl methanolic HCl (3M) were added into 1ml of each lipidomic extract. The tubes were then capped tightly with a Teflon-lined cap and subsequently incubated at 60°C for 20min.
Gas chromatography-mass spectrometry (GC/MS) analysis
Fatty acid methyl esters and other phytochemical compounds, were analyzed by GC-MS using a HP-5MS capillary column (30m× 0.25mm ID, 0.25µm film thickness) in a 7890B gas chromatograph system (Agilent Technologies Co., Santa Clara, USA) coupled to a 5977A mass selective detector. The carrier gas was helium with a constant flow rate of 1.8ml.min -1 . The oven temperature was initially kept at 40ºC for 3min and then ramped at 25ºC.min -1 to 300ºC for 3min. 1.0µl of each sample solution was injected. Mass spectra were obtained by electron ionization (EI) at 70eV. The compounds were identified by comparison of their mass spectra with those of the NIST/EPA/ NIH mass spectral databases.
Statistical analysis
All experiments were carried out in triplicates and the results were presented as the mean± standard deviation (SD). 
Results
In
Determination of the MIC values using broth microdilution assay
The minimum inhibitory concentrations (MICs) of the crude chloroform extract of H.cuneiformis specimens are shown in Table  2 . The obtained results confirm that there is significant and potent antifungal activity for this algal extract against all tested fungal isolates at low concentrations. MICs ranged between 0.78 and 6.25µg.ml -1 . These inhibitory concentrations are considered significant and very close to those of the standard antifungal drug amphotericin B (0.63-5µg.ml -1 ), especially against C. albicans, T. asahii, A. fumigatus and C. herbarum. Phytochemical constituent analysis of the brown seaweed chloroform extract GC-MS analysis of the chloroform extract of the brown seaweed H. cuneiformis investigated in this study revealed that this extract contained 45 different bioactive compounds, which mainly represented saturated and unsaturated fatty acids (18 different species) and some essential oils (25 different compounds), with minor concentrations of the terpene compound phytol and the steroid constituent stigmastan-6,22-dien, 3,5-dedihydro- (Table 3 and Fig. 3 ). Fatty acids had the highest relative concentrations (peak areas) with respect to other phytochemical constituents (71.48%). They ranged from C12:0 to C24:0. Saturated fatty acids (SFAs) were represented by nine different species with a total peak area of approximately 18%. Palmitic (C16:0), myristic (C14:0) and stearic (C18:0) fatty acids were the predominant species with relative concentration values of 9.18, 2.69, and 2.38%, respectively. As far the monounsaturated fatty acids (MUFAs), oleic (C18:1, ω-9) and palmitoleic (C16:1, ω-7) acids had the relative concentrations of 15.61 and 3.3%, respectively. Polyunsaturated fatty acids (PUFAs) constituted the major bulk of the fatty acids with a total peak area of ca. 35%, where arachidonic (C20:4, ω-6), dihomo-γ-linolenic (C20:3, ω-6) and cis-11,14-eicosadienoic (C20:2, ω-6) fatty acids were the most prevailing species. Regarding to the essential oils, although they were represented by a wide array of different compounds, but most of them were onlypresent in lower concentrations as compared to those of fatty acids (check Table 3 for more details).
Discussion
Seaweeds in general have biologically active compounds which are very effective in inhibiting the growth of many pathogenic microorganisms including fungi (e.g., Shobier et al., 2016; Ibraheem et al., 2017; Zerrifi et al., 2018) . In this study, the antifungal activity of the brown seaweed H. cuneiformis was evaluated against eight pathogenic human and plant fungal isolates. The crude seaweed chloroform extract had significant antifungal activities against all tested fungal pathogens, particularly against C. herbarum, A. fumigatus, C. albicans and T. asahii, and inhibited their growths at low MIC values ranged between 0.78 and 6.25µg.ml ). Other algal extracts had no noticeable antifungal effects. This is consistent with Guedes et al. (2012) who showed that apolar extracts, like chloroform, have the best activity against important pathogenic dermatophytes and Candida species. Similarly, Mhadhebi et al. (2012) stated that chloroform extracts of the brown seaweeds Cystoseira crinita and C. sedoides have the maximum antifungal activity against C. albicans. Also, a recent report by Soliman et al. (2018) confirmed that chloroform extract of the red seaweed Gracilaria confervoides has the maximum antifungal activity against the plantinfecting fungus Rhizoctoni asolani. In addition, the published review of Zerrifi et al. (2018) on the seaweed bioactive compounds against pathogens, including fungi, reported that the antimicrobial activity mainly depends upon the type of extraction solvent used as well as the algal species. In this context, our findings support the hypothesis assuming that different solvent extracts from the same seaweed are characterized by different antimicrobial activities based on the polarity of the solvent used and the chemical structures of the bioactive substances extracted (Guedes et al., 2012) . Specimens of the brown seaweed H. cuneiformis investigated in this study had high amounts of fatty acids with variable degrees of saturation indices: SFAs (17.9%), MUFAs (18.91%), and PUFAs (34.68%). These results are is in good agreement with that reported by Heiba et al. (1997) during their study on the brown macroalga H. triquetra (currently regarded as a synonym of H. cuneiformis) collected from the Qatari coasts. They reported 25 different fatty acid species; most of them belonged to the PUFAs (40.9%). The antifungal activity of the H. cuneiformis specimens investigated in this study seems likely ascribed to the synergistic effect exerted by saturated (mainly palmitic, myristic and stearic), monounsaturated ω-9 oleic, and polyunsaturated (particularly arachidonic, dihomo-γ-linolenic and cis-11,14-eicosadienoic) fatty acids, in addition to some essential oils. In accordance with these observations, El Shoubaky & Salem (2014 a) investigated the antibacterial activity of the crude acetone extract of H. triquetra collected from the Red Sea coast in Saudi Arabia and found that this brown seaweed has a remarkable antibacterial activity against the tested bacterial strains due to its high content of fatty acids (65.36%), mainly myristic, palmitic, margaric, oleic, stearic, nonadecanoic, and cis-10-nonadecenoic acids. Also, Ells et al. (2009) found that the polyunsaturated ω-6 arachidonic acid (C20:4) has the potential to increase antifungal susceptibility of biofilms formed by two closely related Candida species, leading to reduction of the dose of the antimycotic agent required to inhibit biofilm formation. Similarly, in other studies, biofilm formation/development of pathogenic fungi Candida albicans and C. dubliniensis have been found to be inhibited by monounsaturated/ polyunsaturated antimicrobial fatty acids, e.g. stearidonic (18:4, n-3), eicosapentaenoic (20:5, n-3), docosapentaenoic (22:5, n-3) , and docosahexaenoic (22:6, n-3) fatty acids and their brominated/acetylene derivatives extracted and purified from different marine algae (Thibane et al., 2010 (Thibane et al., , 2012 . In addition, a review by Pohl et al. (2011) on free fatty acids outlined that the most effective saturated and unsaturated species characterized by antifungal activity. Some of these fatty acids were identified in the chloroform extract analyzed in this study, e.g. lauric (C12:0), myristic (C14:0), palmitic (C16:0), monounsaturated ω-7 palmitoleic (C16:1), monounsaturated ω-9 oleic (C18:1) and polyunsaturated ω-6 linoleic (C18:2) fatty acids. Egypt. J. Bot. 59, No. 3 (2019) ANTIFUNGAL POTENTIAL OF THE BIOACTIVE CONSTITUENTS IN EXTRACTS... Generally, it has been reported that mediumand long-chain unsaturated fatty acids (UFAs) have more antimicrobial activity as compared to saturated fatty acids (SFAs) with the same length of carbon chain (Desbois et al., 2008) . Moreover, there is a significant link between the number of double bonds in UFA carbon chains and FA antimicrobial activity (Feldlaufer et al., 1993) . On the other hand, for the SFAs, the most antimicrobial activity was reported from FAs with 10 or 12 carbons in the chain such as lauric acid (C12:0) (Wille & Kydonieus, 2003) . Accordingly, Altieri et al. (2009) found that lauric acid exerted a strong bioactivity against moulds of F. oxysporum (DSMZ 2018) and F. avenaceum (DSMZ 62151) .
With respect to the mechanism of action, the most important target of antifungal fatty acids is the fungal cell membrane. It is probably that fatty acids caused an increase in membrane fluidity and conformational changes in membrane proteins, resulting in leakage of the fungal intracellular components and finally cell death. This is in agreement with previous studies by Avis & Bélanger (2001) , Desbois & Smith (2010) and Pohl et al. (2011) who discussed in detail the general mechanism of antifungal fatty acids where they supposed that they naturally insert themselves into the lipid bilayer of the fungal membranes, disrupt the membranes and the electron transport chains, leading to an increased fluidity of the membranes. These variable elevations in membrane fluidity will cause a generalized disorganization of the cell membrane, resulting in conformational changes in membrane proteins, release of intracellular components, cytoplasmic disorder and eventually cell disintegration. Thibane et al. (2010) also confirmed that the antifungal activity of PUFAs may be due to their increased motional freedom inside the fungal cell membranes, leading to an increased oxidative stress that had been documented by formation of rough cell walls. In addition, Thibane et al. (2012) found that when biofilms of C. albicans and C. dubliniensis were exposed to certain PUFAs (linoleic acid, stearidonic acid, eicosapentaenoic acid and docosapentaenoic acid), there was an increase in unsaturation index of the cellular membranes and accumulation of intracellular reactive oxygen species (ROS), resulting in a programmed cellular apoptosis. This evidence was supported by reduced mitochondrial membrane potential and nuclear condensation and fragmentation. They also indicated that the most effective PUFA was stearidonic acid.
As for the possible contribution of essential oil to the antifungal activity, Vahdani et al. (2011) in their study on essential oils from five Iranian endemic medicinal plants reported that essential oils, such as tetradecene, tetradecane and hexadecane, have good antimicrobial activity against many microorganisms. Also, Kiruthiga et al. (2011) suggested that the essential oil 'cyclohexene, 4-(4-ethylcyclohexyl)-1-pentyl-', extracted from leaves of the plant Syzygium benthamianum, has a remarkable antifungal effect against Alternaria alternata, Penicillium chrysogenum and Aspergillus niger. All these antifungal compounds have been detected in this study. Recent contribution by Moghaddam et al. (2018) also supported well these observations.
Conclusions
The brown seaweed Hormophysa cuneiformis is highly recommended as an ecofriendly and promising source for bioactive compounds, mainly fatty acids, that can be useful in the treatment and/ or prevention of many human pathogenic fungal diseases and in the management and control of the plant-infecting fungal pathogens, consequently supporting the agricultural sustainable development in Egypt. However, more in-depth phytochemical studies on this interesting and rarely investigated seaweed are still required to expand our little understanding and knowledge on the structure of other powerful pharmaceutical compounds and their mode of action. 
